Discover our impact all over the world.

Numbers displayed on the map are a representation of the activity in each country. Once you use the filter selections below, you will have the opportunity to explore projects and faculty in each country.

Projects + Faculty = Activity Number



Projects 317
Countries 146
Faculty 381
Health Topics 124

Filter from the selections below

Clear All Filters

Drug Resistance Genotypic and Phenotypic Correlates of Efavirenz and Dolutegravir based Treatment Outcomes across Non-B HIV-1 subtypes

Antiretroviral therapy (ART) is critical to improving the health of people living with HIV (PLHIV), to reducing HIV transmission and to maintaining the effectiveness of the current ART programs in resource-limited settings (RLS). However, HIV antiretroviral drug resistance (HIVDR) can hamper efforts to control the AIDS epidemic and achieve the UNAIDS 90-90-90 targets. This proposal seeks to expand our understanding of HIVDR and its correlates and consequences in low and middle income counties where HIV-1 non-B subtypes circulate.

Active Dates 
07/10/2019 to 06/30/2024